Story perspectives

Mapping Immune Cells in Bowel Cancer for Better Treatments

11/6/2025

49 5

Summary

Story summary

Researchers used single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics to map immune cells in bowel cancer.
They used CIBERSORT-ABS to estimate immune cell proportions and analyzed correlations with fibroblast-related gene expressions.
They inferred regulatory networks at the single-cell level and found significant transcription factor–gene interactions.
The results suggest that understanding immune microenvironments could improve treatment strategies and support integrating genomic data for prognosis and personalized therapies.

1 of 1

Story summary

Researchers used single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics to map immune cells in bowel cancer.
They used CIBERSORT-ABS to estimate immune cell proportions and analyzed correlations with fibroblast-related gene expressions.
They inferred regulatory networks at the single-cell level and found significant transcription factor–gene interactions.
The results suggest that understanding immune microenvironments could improve treatment strategies and support integrating genomic data for prognosis and personalized therapies.